4.5 Review

Cancer stem cells and hepatocellular carcinoma

期刊

CANCER BIOLOGY & THERAPY
卷 8, 期 18, 页码 1691-1698

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.8.18.9843

关键词

TGF; 2-SPECTRIN; stem/progenitor cells; hepatocellular cancer; signal transduction

类别

资金

  1. NCI NIH HHS [R01 CA042857, R01 CA106614, P01 CA130821] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK056111] Funding Source: Medline

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, with a median survival of 6-16 m. Factors responsible for the poor prognosis include late onset diagnosis, underlying cirrhosis and resistance to chemotherapy; 40% of HCCs are clonal and therefore potentially arise from progenitor/stem cells. New insights are provided from several signaling pathways, such as STAT3, NOTCH, hedgehog and transforming growth factor-beta (TGF beta), which are involved in stem cell renewal, differentiation, survival, and are commonly deregulated in HCC. Control of stem cell proliferation by the TGF beta, Notch, Wnt and Hedgehog pathways to suppress hepatocellular cancer and to form the endoderm suggest a dual role for this pathway in tumor suppression as well as progression of differentiation from a stem or progenitor stage. This review provides a rationale for detecting and analyzing tumor stem cells as one of the most effective ways to treat cancers such as hepatocellular cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据